We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
CN Bio Innovations secures licence from Bristol-Myers Squib to combine small molecule programme with liver-on-a-chip technologies to tackle Hepatitis.
SpyBiotech, an Oxford University spinout developing a molecular superglue for rapid development of vaccines targeting a range of diseases, secures £4m seed funding at launch, led by Oxford Sciences Innovation with participation from GV.
The Germany-based diagnostics firm is licencing out Oxford technologies to support the development of its in-vitro diagnostics for MS.
Dr Stoten will be taking over from retiring Managing Director Linda Naylor from April.
Oxford Cancer Biomarker’s ColoTox test will now be available to UK patients considering chemotherapy.
New research supports the Oxford University Incubator startup’s challenge to Amazon Mechanical Turk’s dominance in sourcing participants for social science studies.
Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.
Following research showing Oxford University has produced more founders of billion-dollar startups than any other institution in Europe, Oxford University Innovation’s Gregg Bayes-Brown takes a closer look at the founders, their ties to Oxford, and the companies they’ve launched.
Oxford University Innovation’s management consultancy division to restructure as separate entity to scale up interactions and business on the world stage.
